Medications
Compounded Semaglutide, Compounded Tirzepatide
Monthly Cost
$199-$349/mo
Speed to Start
Fast
Compounded Medications
Est. 2022
About Belle
Belle is a GLP-1 telehealth provider founded in 2022 that offers compounded semaglutide and tirzepatide with pricing between $199 and $349 per month. What immediately sets Belle apart from nearly every competitor in this space is its A+ rating from the Better Business Bureau, a distinction that is exceedingly rare among GLP-1 telehealth providers. In a market where F ratings are common, Belle’s BBB standing signals a meaningfully different approach to customer service and complaint resolution.
The A+ BBB rating is not just a vanity metric. It indicates that Belle responds to and resolves consumer complaints at a rate the BBB considers exemplary. For patients who have been burned by other telehealth platforms with opaque refund policies or unresponsive support teams, this track record provides a degree of assurance that is genuinely hard to find elsewhere. Our editorial team views this as Belle’s single most important competitive advantage.
On Trustpilot, Belle carries a 4.4-star rating from 560+ reviews. The review volume is moderate but growing, and the 4.4-star score aligns well with the BBB data in suggesting a company that takes patient satisfaction seriously. Positive reviews highlight responsive customer support and clear communication about the treatment process. Negative reviews, where they exist, tend to focus on medication side effects rather than operational failures, which is a qualitatively different complaint profile than most competitors.
Belle’s clinical model provides medium-level support, including some structured follow-up and communication touchpoints beyond the initial prescription. This is not a full-service weight management program with dietitians and lab panels, but it offers more ongoing engagement than the bare-minimum providers in the market. Pricing is competitive without being the cheapest, positioning Belle in a value-oriented middle ground that balances cost, support, and accountability.
In our assessment, Belle represents one of the better risk-adjusted options in the compounded GLP-1 space. The A+ BBB rating provides a layer of consumer protection that most alternatives simply cannot match. Combined with solid Trustpilot scores and reasonable pricing, Belle offers a package that should appeal to patients who have done their research and want a provider with a demonstrated commitment to resolving issues when they arise.
At a Glance
Medications Offered
Compounded Semaglutide, Compounded Tirzepatide
Compounded
Cost & Insurance
- Monthly: $199-$349/mo
- 6-month estimate: $1,194-$2,094
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Verified Pharmacy: Partner pharmacy not named publicly; FDA warning letter Feb 2026 for labeling medications with Belle branding (misleading compounder identity)
- BBB Rating: A+
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
Start your GLP-1 weight loss journey with Belle today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Belle Intake Looks Like
We walked through Belle’s intake ourselves, from the opening “Let’s get started” welcome through medical history, a named GLP-1 drug allergy screen, medication selection, and the final treatment plan with a non-refundable 6-month charge.
Solid medical history coverage. Personal-or-family MTC, pancreatitis or pancreatic cancer, gastroparesis, IBD, hypertriglyceridemia, kidney injury, 6-month bariatric recency, a named GLP-1 brand allergy screen, and a named diabetes drug interaction screen covering sulfonylureas and DPP-4 inhibitors.
Moderate. The intake is fast at ~5 minutes, but the default 6-month plan bills $1,194 up front and Belle’s checkout warns that orders cannot be canceled or refunded once processing begins. Read that line carefully.
The 8 Stages
Belle is one of the few platforms we’ve audited that asks a dedicated “Are you allergic to any of the following medications?” screen naming Ozempic, Wegovy, Zepbound, Mounjaro, and Saxenda by brand. Most intakes lean on a generic “do you have any allergies” yes/no. Belle pairs that generic gate with a specific GLP-1 brand allergy screen — clinically meaningful because a prior severe reaction to one semaglutide or tirzepatide product is a direct contraindication to compounded versions of the same molecule.
Belle’s drug interaction screen names sulfonylureas (glimepiride / Amaryl, glipizide / Glucotrol XL, glyburide / Micronase / Glynase / Diabeta) and DPP-4 inhibitors (sitagliptin, saxagliptin, linagliptin, alogliptin) in addition to insulin. That matters because GLP-1 receptor agonists combined with insulin or sulfonylureas materially increase hypoglycemia risk, and most GLP-1 intakes either ask a generic “are you on any medications” field or skip drug-interaction screening entirely. Belle handles it as a structured gate in the written flow.
The Belle treatment plan page carries an explicit warning: “Please note: Orders begin processing immediately, so once placed, they cannot be canceled or refunded.” The default 6-month plan bills $1,194 in a single charge today, dropping the monthly rate to $199 — but that’s a real lump-sum commitment, not a monthly subscription. Patients evaluating Belle should understand that picking the lowest-monthly-cost option means the refund path closes at the moment the order is placed, and that the optional MIC+B12 ($139) and NAD+ ($149) upsells are subject to the same no-refund rule.
No eating disorder screen, no pregnancy or breastfeeding screen, no validated PHQ or mental-health instrument, no substance use or alcohol screen, no self-reported blood pressure or resting heart rate, and no MEN-2 gate split out from the personal-or-family MTC question. No ID upload and no phone OTP. Belle’s strengths are concentrated in the named drug-allergy and drug-interaction screens; its clinical net is narrower than the high-rigor tier of the catalog.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Belle intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens joinbelle.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
